These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 9306958)
1. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. Hanski C; Hofmeier M; Schmitt-Gräff A; Riede E; Hanski ML; Borchard F; Sieber E; Niedobitek F; Foss HD; Stein H; Riecken EO J Pathol; 1997 Aug; 182(4):385-91. PubMed ID: 9306958 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of the chromosome 11 mucin genes in colorectal cancer. Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777 [TBL] [Abstract][Full Text] [Related]
5. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
6. MUC2 is a molecular marker for pseudomyxoma peritonei. O'Connell JT; Hacker CM; Barsky SH Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214 [TBL] [Abstract][Full Text] [Related]
7. Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines. Tamada Y; Iida S; Aoki D; Nozawa S; Irimura T Oncol Res; 1999; 11(5):233-41. PubMed ID: 10608618 [TBL] [Abstract][Full Text] [Related]
8. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744 [TBL] [Abstract][Full Text] [Related]
9. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022 [TBL] [Abstract][Full Text] [Related]
11. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Blank M; Klussmann E; Krüger-Krasagakes S; Schmitt-Gräff A; Stolte M; Bornhoeft G; Stein H; Xing PX; McKenzie IF; Verstijnen CP Int J Cancer; 1994 Nov; 59(3):301-6. PubMed ID: 7927933 [TBL] [Abstract][Full Text] [Related]
12. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study. Yamato T; Sasaki M; Watanabe Y; Nakanuma Y J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243 [TBL] [Abstract][Full Text] [Related]
14. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444 [TBL] [Abstract][Full Text] [Related]
15. [Ovarian mucinous tumor of gastric and intestinal type associated with Peutz-Jeghers syndrome: in situ hybridization study of apomucin gene transcripts]. Wacrenier A; Boman F; Farine MO; Durand-Reville M; Buisine MP; Porchet N; Aubert JP; Querleu D; Gosselin B Ann Pathol; 1998 Dec; 18(6):497-501. PubMed ID: 10051919 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Lau SK; Weiss LM; Chu PG Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Albarracin CT; Jafri J; Montag AG; Hart J; Kuan SF Hum Pathol; 2000 Jun; 31(6):672-7. PubMed ID: 10872659 [TBL] [Abstract][Full Text] [Related]
18. HATH1 expression in mucinous cancers of the colorectum and related lesions. Park ET; Oh HK; Gum JR; Crawley SC; Kakar S; Engel J; Leow CC; Gao WQ; Kim YS Clin Cancer Res; 2006 Sep; 12(18):5403-10. PubMed ID: 17000673 [TBL] [Abstract][Full Text] [Related]
19. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498 [TBL] [Abstract][Full Text] [Related]
20. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study. Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]